EUVIMEDEUVIMED entdecken
Crossref

Plasma itraconazole concentrations during treatment of feline sporotrichosis

Gabriela Reis Pereira-Oliveira iD, Isabella Dib Ferreira Gremião, Maria Lopes Corrêa, Cindy Caroline Dos Santos Honorato, Paula Gonçalves Viana, Anna Barreto Fernandes Figueiredo, Jéssica Sepúlveda Boechat iD, Érica Guerino Dos Reis, Raquel de Vasconcelos Carvalhaes Oliveira, Aline Campos de Azevedo da Silva, Thiago Santana Novotny, Lusiele Guaraldo und 1 weitere

Medical Mycology · 02.08.2024 · 62 (8)

DOI: 10.1093/mmy/myae076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, online erschienen am 24.07.2024. Verfasst von Gabriela Reis Pereira-Oliveira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Sporotrichosis, Itraconazole, Cat Diseases, Antifungal Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Itraconazole (ITZ) is the most used drug to treat feline sporotrichosis; however, little is known about its pharmacokinetics in cats with this mycosis. The aim of this study was to determine plasma ITZ concentrations in cats with sporotrichosis treated with ITZ as monotherapy or in combination with potassium iodide (KI). Cats diagnosed with sporotrichosis received orally ITZ (100 mg/cat/day) or combination therapy with ITZ (100 mg/cat/day) and KI (2.5–5 mg/kg/day) in the case of worsening or stagnation of the clinical condition. At each monthly visit, blood samples were collected at an interval of 4 h for analysis of trough and peak plasma ITZ concentrations by HPLC. Clinical features and laboratory parameters were evaluated during follow-up. Sixteen cats were included in the study. The median plasma ITZ concentration of all cats was 0.75 µg/mL. The median plasma ITZ concentration was 0.5 µg/mL in cats that received ITZ monotherapy (n = 12) and 1.0 µg/mL in those treated with ITZ + KI (n = 4). The clinical cure rate was 56.3% (n = 9) and the median treatment duration was 8 weeks. Nine cats (56.3%) developed adverse clinical reactions, and hyporexia was the most frequent (n = 8; 88.9%). Serum alanine aminotransferase was elevated in four cats (25%). The median plasma ITZ concentration detected in cats was considered to be therapeutic (>0.5 µg/mL) and was reached after 4 weeks of treatment. Plasma ITZ concentrations were higher in cats that received ITZ + KI compared to those treated only with ITZ, suggesting pharmacokinetic synergism between these drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SporotrichosisItraconazoleCat DiseasesAntifungal AgentsPotassium IodideAnimalsCatsMaleFemaleTreatment OutcomeDrug Therapy, CombinationAdministration, OralPlasma

Stichwörter der Autor:innen

Sporothrixcatsitraconazoleplasmapotassium iodide

Substanzen

ItraconazoleAntifungal AgentsPotassium Iodide

Autor:innen und Institutionen

  • Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
  • Biosafety Advisory, Quality Vice-Directory, The Institute of Technology on Immunobiologicals (Bio-Manguinhos), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
  • Laboratory of Clinical Epidemiology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Equivalence and Pharmacokinetics Service (Sefar), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
  • Medicines Sector, National Institute for Quality Control in Health (INCQS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
  • Clinical Research Laboratory on Acute Febrile Illnesses, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.

ORCID-Profile: Gabriela Reis Pereira-Oliveira, Jéssica Sepúlveda Boechat

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • CNPq

Zitieren

APA

Pereira-Oliveira, G. R., Gremião, I. D. F., Corrêa, M. L., Caroline Dos Santos Honorato, C., Gonçalves Viana, P., Figueiredo, A. B. F., Boechat, J. S., Guerino Dos Reis, É., Oliveira, R. V. C., da Silva, A. C. A., Novotny, T. S., Guaraldo, L., & Pereira, S. A. (2024). Plasma itraconazole concentrations during treatment of feline sporotrichosis. Medical Mycology, 62(8). https://doi.org/10.1093/mmy/myae076

Vancouver

Pereira-Oliveira GR, Gremião IDF, Corrêa ML, Caroline Dos Santos Honorato C, Gonçalves Viana P, Figueiredo ABF, et al. Plasma itraconazole concentrations during treatment of feline sporotrichosis. Medical Mycology. 2024;62(8). doi:10.1093/mmy/myae076

BibTeX
@article{PereiraOliveira2024,
  author = {Pereira-Oliveira, Gabriela Reis and Gremião, Isabella Dib Ferreira and Corrêa, Maria Lopes and Caroline Dos Santos Honorato, Cindy and Gonçalves Viana, Paula and Figueiredo, Anna Barreto Fernandes and Boechat, Jéssica Sepúlveda and Guerino Dos Reis, Érica and Oliveira, Raquel de Vasconcelos Carvalhaes and da Silva, Aline Campos de Azevedo and Novotny, Thiago Santana and Guaraldo, Lusiele and Pereira, Sandro Antonio},
  title = {Plasma itraconazole concentrations during treatment of feline sporotrichosis},
  journal = {Medical Mycology},
  year = {2024},
  volume = {62},
  number = {8},
  doi = {10.1093/mmy/myae076}
}
Kostenlos starten →